![Combined gemcitabine, ifosfamide and vinorelbine (GIN): activity and safety of a non-platinum-based regimen in advanced non-small-cell lung cancer (NSCLC)]()
Combined gemcitabine, ifosfamide and vinorelbine (GIN): activity and safety of a non-platinum-based regimen in advanced non-small-cell lung cancer (NSCLC)Baldini, E.; Ardizzoni, A.; Cafferata, M.A.; Del Freo, A.; Boni, L.; Tibaldi, C.; Chella, A.; Conte, P.F.; Rosso, R. · European Journal of Cancer · 1999